Maximum 53,500,000* shares of common stock ("Medex Tokens" or "MDX") ($1,070,000)
*Maximum subject to adjustment for bonus shares. See 10% Bonus below
Minimum 500,000 shares of common stock ("Medex Tokens" or "MDX") ($10,000)
|Company||Citizen Health Project, Inc.|
A Delaware Public Benefit Corporation
|Corporate Address||6641 Hwy 98 Suite 200|
Hattiesburg, MS 39402
|Description of Business||A decentralized health economy owned & governed by the people|
|Type of Security Offered||Common Stock (Designated as "Medex" or "MDX" tokens)|
|Purchase Price of Security Offered||$0.02|
|Minimum Investment Amount (per investor) ||$400|
$400+ You are first to beta test Humantiv and can earn bounties**
$5,000+ Same as above, plus a 20% bonus of Medit tokens (not Medex) preloaded in your Humantiv account**
$50,000+ Same as above, plus our microbiome and genetic test along with personal analysis & interpretation
$70,000+ Same as above, plus our "Healthy Home" digital diagnostic kit.
$100,000+ Same as above, plus a free year of a family subscription.
*All perks and tokens will be delivered after the campaign is completed, and upon availability of the Tokens.
**Humantiv is our first application and also the operating system for Citizen Health. We have a dual-token structure: a stable currency called Medit that is pegged at $1 USD, and a token called Medex which represents a share of Common Stock in Citizen Health.
Terms of Tokens
Medex Tokens (Common Stock)
Description: The Medex Tokens will represent a single share of Common Stock of the company, with rights and preferences as designated in the articles of incorporation and summarized in the Offering Document.
- Blockchain: ERC20
- Exchanges: Tokens intended to be tradable on StartEngine LDGR, tZero, and any other ATS upon launch of the service.
- Voting Rights: 1 vote
- Restrictions on Transfer: 1 year
- Dividends/Distributions: at the discretion of the board
- Redemption Rights: None
Please see Offering Document for complete set of rights and preferences.
The right to receive future tokens and the offering of future tokens is being offered as part of this offering exempt from registration under Regulation CF. The promise of future tokens is contingent upon the successful development of such items. There is no guarantee that successful development will ever occur.
Tax Advisory: Investors should consult their tax advisors with respect to the tax basis for Medex tokens.
The 10% Bonus for StartEngine Shareholders
Citizen Health Project, Inc. will offer 10% additional bonus shares for all investments that are committed by StartEngine Crowdfunding Inc. shareholders (with ≥ $1,000 invested in the StartEngine Reg A+ campaign) within 24 hours of this offering going live.
StartEngine shareholders who have invested $1,000+ in the StartEngine Reg A+ campaign will receive a 10% bonus on this offering within a 24-hour window of their campaign launch date. This means you will receive a bonus for any shares you purchase. For example, if you buy 5,000 shares of Common Stock (Designated as "Medex" or "MDX") at $0.02 / share, you will receive 500 Common Stock (Designated as "Medex" or "MDX") bonus shares, meaning you'll own 5,500 shares for $100. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid for one year from the time StartEngine Crowdfunding Inc. investors receive their countersigned StartEngine Crowdfunding Inc. subscription agreement.
A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.